Burning Rock Biotech (BNR)
(Delayed Data from NSDQ)
$3.58 USD
+0.35 (10.84%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $3.49 -0.09 (-2.51%) 6:22 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
BNR 3.58 +0.35(10.84%)
Will BNR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BNR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BNR
Is Burning Rock Biotech (BNR) Outperforming Other Business Services Stocks This Year?
Mogo Inc (MOGO) Reports Q4 Loss, Tops Revenue Estimates
BNR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Usio Inc (USIO) Reports Q4 Loss, Tops Revenue Estimates
Outbrain Inc. (OB) Reports Q4 Loss, Tops Revenue Estimates
Burning Rock Biotech Limited Sponsored ADR (BNR) Upgraded to Buy: What Does It Mean for the Stock?
Other News for BNR
Bulletin Resources Acquires 10.7% of Matsa
GLOBAL BROKER RATINGS: BofA raises Diageo, RBC raises Commerzbank
GLOBAL BROKER RATINGS: Exane raises Compass; Metzler likes Brenntag
GLOBAL BROKER RATINGS: HSBC raises Moderna; Citi cuts Kingfisher
Burning Rock Biotech GAAP EPS of -$0.14, revenue of $18.7M